TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
OSTX

OS Therapies Incorporated

Healthcare · Biotechnology

1.70$ +0.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OSTX
Line item 2020 2021 2022 2023 2024 2025
– -100.0% +56.2% +56.8% +594.0% +23.5%
– -100.0% +58.8% +59.0% +600.4% -94.0%
– -100.0% +112.3% -77.3% +14,095.1% -95.1%
– -100.0% +112.3% -77.3% +14,095.1% -95.1%
– -99.9% -99.5% – – –
– – – – – –
– -99.9% +53.4% +37.4% -80.9% +173.6%
– -99.8% +75.8% +302.0% -81.3% +154.2%
– +85.0% -99.8% +380.8% – –
– +2,041.3% +43.0% +121.6% -38.8% +497.8%
– – +46.3% – – –
– – – – – -851.2%
– – – – – –
– +174.3% +0.0% -13.2% +4.1% +40.2%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?